Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CPRX [NASD]
Catalyst Pharmaceutical Partners Inc.
Index- P/E- EPS (ttm)-0.22 Insider Own9.50% Shs Outstand69.11M Perf Week-0.94%
Market Cap182.10M Forward P/E- EPS next Y-0.21 Insider Trans13.29% Shs Float62.46M Perf Month-1.68%
Income-13.40M PEG- EPS next Q-0.06 Inst Own35.90% Short Float7.38% Perf Quarter2.13%
Sales- P/S- EPS this Y-92.90% Inst Trans9.81% Short Ratio3.29 Perf Half Y29.17%
Book/sh0.54 P/B4.88 EPS next Y12.50% ROA-38.50% Target Price7.00 Perf Year48.87%
Cash/sh0.60 P/C4.39 EPS next 5Y- ROE-45.90% 52W Range1.65 - 3.49 Perf YTD35.13%
Dividend- P/FCF- EPS past 5Y19.70% ROI- 52W High-24.50% Beta0.78
Dividend %- Quick Ratio7.80 Sales past 5Y- Gross Margin- 52W Low59.70% ATR0.16
Employees7 Current Ratio7.80 Sales Q/Q- Oper. Margin- RSI (14)45.43 Volatility4.79% 5.98%
OptionableYes Debt/Eq0.00 EPS Q/Q46.20% Profit Margin- Rel Volume0.22 Prev Close2.66
ShortableYes LT Debt/Eq0.00 EarningsNov 13 Payout- Avg Volume1.40M Price2.63
Recom2.00 SMA20-4.55% SMA50-4.79% SMA20010.24% Volume312,308 Change-0.94%
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Sep-06-13Reiterated Aegis Capital Buy $3.50 → $4
Apr-18-13Initiated Aegis Capital Buy $2.50
Aug-27-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
Oct-01-09Upgrade Merriman Sell → Neutral
May-29-09Downgrade Merriman Curhan Ford Buy → Sell
May-29-09Downgrade Hapoalim Neutral → Underperform
Dec-15-08Initiated Merriman Curhan Ford Buy
Nov-28-07Initiated Rodman & Renshaw Mkt Outperform $9
Jan-31-07Initiated Stifel Nicolaus Buy $9
Jan-05-07Initiated First Albany Buy $10
Nov-21-14 01:04PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Financials EDGAR Online Financials
Nov-15-14 07:07PM  10-Q for Catalyst Pharmaceutical Partners, Inc. Company Spotlight
Nov-14-14 08:17AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.01%
08:03AM  Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial Results GlobeNewswire
Nov-13-14 04:46PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-12-14 04:30PM  Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? Zacks
Nov-04-14 08:21AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action Lawsuit GlobeNewswire
Oct-28-14 08:03AM  Catalyst Pharmaceuticals Appoints David J. Caponera as Vice President Patient Advocacy and Reimbursement GlobeNewswire
Oct-27-14 08:03AM  Catalyst Pharmaceuticals to Present Firdapse Phase 3 Trial Results at the 61st Annual Meeting of the American Association of Neuromuscular and Electrodiagnostic Medicine GlobeNewswire
Oct-08-14 01:11PM  Midday Gainers From October 8 - GT Advanced Technologies Inc, Unilife Corp And More Benzinga +6.43%
08:03AM  Catalyst Pharmaceuticals to Present Top-Line Safety and Efficacy Results From Phase 3 Firdapse Trial at 139th Annual Meeting of the American Neurological Association GlobeNewswire
Oct-03-14 09:41AM  Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma at TheStreet
Oct-02-14 08:03AM  Catalyst Pharmaceuticals to Present at 13th Annual BIO Investor Forum GlobeNewswire
Sep-30-14 04:18PM  What Else Is Under the Hood for Catalyst Pharma? at 24/7 Wall St. +11.04%
03:09PM  Why Catalyst Pharmaceutical Partners (CPRX) Stock Is Spiking Today at TheStreet
07:20AM  Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug at TheStreet
Sep-29-14 05:48PM  Ford slips on Europe woes, Cintas, Synnex up on earnings at MarketWatch
04:10PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:05PM  Catalyst Pharma's lead drug succeeds in late-stage study Reuters
04:03PM  Catalyst Pharmaceuticals Announces Positive Top-Line Phase 3 Data From Pivotal Firdapse Clinical Trial in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
Sep-05-14 06:38AM  Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% Zacks
Sep-04-14 08:45AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +8.95%
08:03AM  Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development GlobeNewswire
Sep-03-14 08:03AM  Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 16th Annual Global Investment Conference GlobeNewswire
Sep-02-14 04:21PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Initiates Phase 1(b) Safety and Tolerance Study for CPP-115 GlobeNewswire
Aug-28-14 06:48AM  Why Catalyst Pharmaceutical (CPRX) Could Be Positioned for a Surge? Zacks
Aug-26-14 09:50AM  Your September Biotech Back-to-School Calendar at TheStreet +15.89%
07:50AM  Catalyst Pharmaceutical Partners (CPRX) Worth Watching: Stock Up 10.3% Zacks
Aug-14-14 08:15AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Announces Second Quarter 2014 Financial Results GlobeNewswire
Aug-13-14 04:38PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Aug-11-14 08:15AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Provides Updates on Progress of Phase 3 Firdapse Study in Patients With Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
Aug-01-14 08:06AM  Biotech Stock Mailbag: Arrowhead, Catalyst Pharma at TheStreet
Jun-19-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference GlobeNewswire
Jun-18-14 01:03PM  Catalyst Pharmaceutical Partners Set to Join Russell Microcap(R) Index GlobeNewswire
May-29-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the Jefferies 2014 Global Healthcare Conference GlobeNewswire +5.83%
May-19-14 04:20PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of M EDGAR Online
May-16-14 08:28AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:06AM  Catalyst Pharmaceutical reports Q1 EPS (4c), consensus (6c) at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Announces First Quarter 2014 Financial Results and Provides Corporate Update GlobeNewswire
May-15-14 07:00PM  The Shuman Law Firm Investigates Catalyst Pharmaceutical Partners, Inc. Business Wire
04:28PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Apr-23-14 08:40AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Announces Initiation of an Expanded Access Program to Provide Firdapse at No Cost to U.S. Patients with Lambert-Eaton Myasthenic Syndrome Business Wire
Apr-17-14 04:56PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online
Apr-09-14 02:58PM  A Small-Cap Biotech Stock on the Verge of a Breakout at TheStreet
Apr-08-14 10:58AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +7.77%
10:30AM  Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced Public Offering GlobeNewswire
Apr-04-14 02:01AM  Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% Zacks -5.83%
Apr-03-14 04:32PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +8.60%
09:00AM  Catalyst Pharmaceutical Partners, Inc. Prices Public Offering of Common Stock GlobeNewswire
Apr-02-14 04:05PM  Catalyst Pharmaceutical files to sell common stock, no amount given at theflyonthewall.com
04:04PM  Catalyst Pharmaceutical Partners, Inc. Announces Commencement of Public Offering of Common Stock GlobeNewswire
Apr-01-14 12:59PM  [$$] 7 Stock Picks From an Insider Trading Guru at Barrons.com
08:19AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Announces Completion of Enrollment in Pivotal Phase 3 Trial of Firdapse(TM) in Patients With Lambert-Eaton Myasthenic Syndrome GlobeNewswire
Mar-28-14 08:36AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:06AM  Catalyst Pharmaceutical names Barrett McGrath as Chief Commercial Officer theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Expands Executive Leadership Team to Support the Commercialization of Firdapse(TM) GlobeNewswire
Mar-26-14 05:30PM  Good News for Catalyst Pharma Zacks
Mar-25-14 04:51PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:03AM  Catalyst Pharmaceutical Partners Announces Recommendation of Data Monitoring Committee to Continue Pivotal Phase 3 Clinical Trial for Firdapse(TM) GlobeNewswire
Mar-21-14 06:11AM  Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher Zacks
Mar-20-14 05:17PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.22%
08:20AM  Narrower-than-Expected Loss at Catalyst Pharma Zacks
Mar-19-14 08:03AM  Catalyst Pharmaceutical Partners Announces Fourth Quarter and Year-End 2013 Financial Results and Provides Corporate Update GlobeNewswire
06:02AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-K, Annual Report EDGAR Online
Mar-06-14 08:03AM  Catalyst Pharmaceutical Partners to Present at the 26th Annual ROTH Conference GlobeNewswire
Mar-04-14 05:03PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD D EDGAR Online
Feb-28-14 08:03AM  Catalyst Pharmaceutical Partners Observes Rare Disease Day Today GlobeNewswire
Feb-20-14 04:34PM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Stat EDGAR Online +11.68%
Feb-06-14 08:03AM  Catalyst Pharmaceutical Partners to Present at 16th Annual BIO CEO & Investor Conference GlobeNewswire
Jan-08-14 08:24AM  CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.94%
08:03AM  Catalyst Pharmaceutical Partners Reports Positive Cardiac Safety Results of Its Phase 3 Product, Firdapse Tablets GlobeNewswire
Jan-07-14 08:14AM  Catalyst Pharmaceutical announces dismissal of stockholder class action lawsuit at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Reports Dismissal of Stockholder Class Action Lawsuit GlobeNewswire
Jan-06-14 08:15AM  Catalyst reports successful completion of Type B therapy meeting with FDA at theflyonthewall.com
08:03AM  Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program GlobeNewswire
Dec-20-13 09:30PM  Glancy Binkow & Goldberg LLP Announces a December 24, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. -- CPRX GlobeNewswire
Dec-17-13 06:50PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 Business Wire
03:14AM  EQUITY ALERT: Rosen Law Firm Reminds Catalyst Pharmaceutical Partners Investors of Important December 24, 2013 Deadline in Class Action -- CPRX GlobeNewswire
Dec-12-13 12:27PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Catalyst Pharmaceutical Partners, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 24, 2013 -- CPRX Marketwired
Dec-10-13 09:32PM  Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
Dec-09-13 04:21PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Catalyst Pharmaceutical Partners, Inc. of Upcoming Deadline Business Wire -6.22%
Dec-06-13 09:32PM  Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc. Business Wire
Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. The company focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. Its principal product candidate is Firdapse, a proprietary form of amifampridine phosphate, which is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. The company also develops CPP-115, a vigabatrin analog to treat infantile spasms and epilepsy, as well as other neurological conditions associated with reduced GABAergic signaling, such as post-traumatic stress disorder and Tourette syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Winship M DouglasVP, Regulatory OperationsOct 17Option Exercise0.90125,000112,500142,294Oct 20 04:34 PM
Tierney David SDirectorOct 16Option Exercise0.9030,00027,000243,401Oct 20 04:33 PM
MUTH DAVID DExec. V.P., Corp. DevelopmentOct 03Buy2.6510,00026,50020,000Oct 07 04:26 PM
MCENANY PATRICK JPresident and CEOOct 02Option Exercise0.90150,000135,0003,920,918Oct 03 01:03 PM
GRANDE ALICIAVP, Treasurer and CFOOct 02Option Exercise0.9090,00081,000156,346Oct 03 12:56 PM
O'Keeffe Charles BDirectorOct 02Option Exercise0.90105,00094,500297,126Oct 03 02:25 PM
Miller SteveChief Operating OfficerOct 02Option Exercise0.90175,000157,500389,754Oct 03 02:26 PM
HUCKEL HUBERT E MDDirectorOct 02Option Exercise0.9030,00027,0001,334,134Oct 06 04:29 PM
COELHO PHILIP HDirectorOct 02Option Exercise0.9020,03618,032141,636Oct 06 04:28 PM
Miller SteveChief Operating OfficerJun 04Buy2.17100,000216,990214,754Jun 04 06:39 PM
MCENANY PATRICK JPresident and CEOMay 21Buy1.8925,00047,2253,656,247May 21 04:15 PM
O'Keeffe Charles BDirectorMay 19Buy1.8310,00018,291192,126May 21 04:13 PM
O'Keeffe Charles BDirectorApr 16Buy2.025,00010,100182,126Apr 17 07:56 PM
MCENANY PATRICK JPresident and CEOFeb 07Buy1.8225,00045,5003,631,247Feb 07 02:04 PM
O'Keeffe Charles BDirectorFeb 05Buy1.8110,00018,099177,126Feb 06 04:08 PM